Pfizer, Inc. Common Stock (PFE)
Pfizer, Inc. Common Stock (PFE)
$42.74 USD
Updated Jul 17 4:02pm
Add PFE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
PFE News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Pfizer, Inc. Common Stock (PFE) Company Bio
Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel, among others. The company was founded in 1849 and is based in New York, New York.
PFE Stock Chart More Charts
PFE Price/Volume Stats
| Current price | $42.74 |
| Prev. close | $42.85 |
| Day low | $42.73 |
| Day high | $43.19 |
| 50-day MA | $42.52 |
| 200-day MA | $42.66 |
| 52-week high | $46.47 |
| 52-week low | $37.12 |
| Volume | 15,504,200 |
| Avg. volume | 23,601,482 |
| Dividend yield | 3.36% |
| Market Cap | 237.63B |
PFE Returns
| 1-mo | -0.77% |
| 3-mo | 9.49% |
| 6-mo | 2.27% |
| 1-year | 17.38% |
| 3-year | 30.14% |
| 5-year | 66.28% |
| YTD | -0.35% |
| 2018 | 24.82% |
| 2017 | 15.90% |
| 2016 | 4.42% |
| 2015 | 7.09% |
| 2014 | 5.28% |
PFE Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...